Investigation of Clinical and Functional Characteristics of Endocrinology Patients During Hospitalization

Assessment of respiratory functions

时间窗: At the time of enrollment

Respiratory rate: Respiratory rate provides important information in the diagnosis of respiratory problems and in the evaluation of the general health status of the individual. The number of breaths the individual takes in a minute (how many times the chest rises) will be counted. During the evaluation, the hands will be placed on the patient's chest and the movements in the chest wall will be felt and the counts made during rest, inspiration and expiration will be evaluated.

Chest circumference measurement

时间窗: At the time of enrollment

Chest circumference measurement: Respiratory function is an important parameter for monitoring and evaluating respiratory functions. The measurement will be taken at the level of the fourth rib, where the lower end of the scapula passes, while standing with the arms abducted. The measurement will be made twice during rest, inspiration and expiration. Thus, chest mobility will also be evaluated.

Assessment of muscle strength

时间窗: At the time of enrollment

Manual Muscle Testing: Manual muscle testing is used to assess the muscle strength of individuals and identify possible weaknesses or imbalances. The strength of large muscle groups such as quadriceps femoris and biceps brachii is essential for individuals to carry out their daily activities. Weakness in these muscles can negatively affect a person's independence and quality of life. In our study, muscle strength will be assessed with a score between 0 and 5 (0: no muscle contraction is felt, 5: full movement of the segment against gravity and with maximum resistance).

Pain assessment

时间窗: At the time of enrollment

Pain assessment will be done with Visual Analog Scale (VAS). VAS includes a scale with a starting and ending point on a line to evaluate a specific feature. Individuals evaluate the severity of their condition by placing a mark on this line. In this scale, 0 represents the absence of a specific feature or no sensation, and 10 represents the highest intensity of that feature. In our study, it was used to evaluate general health status.

Quality of life assessment

时间窗: At the time of enrollment

Short Form-36 Health Survey (SF-36) was developed by John E. Ware and colleagues (1992) to measure health-related quality of life. It consists of a total of 36 questions covering physical, psychological and social dimensions. Sub-dimensions: Physical Function, Social Function, Body Pain, General Health, Mental Health, Vitality, Physical Role and Emotional Role. Scores calculated for each subscale range from 0 to 100, where higher scores indicate better health status, functioning and quality of life.

Fatigue assessment

时间窗: At the time of enrollment

Functional Assessment of Chronic Illness Therapy (FACIT): FACIT is a scale developed to assess the level of fatigue that individuals experience, particularly due to chronic diseases. This scale, consisting of a total of 13 questions, measures the level of fatigue and energy experienced by individuals in the last week. Each item on the FACIT scale is scored between 0 and 4; responses range from "never" to "very often." The total score obtained ranges from 0 to 52, with higher scores indicating lower fatigue and better quality of life.

Assessing their independence in activities of daily living

时间窗: At the time of enrollment

Assessment of independence in daily living activitiesBarthel Index: It will be assessed with the Barthel Index. The Barthel index was developed by Florence I. Mahoney and Dorothy W. Barthel in 1965. It is used to assess the level of independence in daily living activities. Scoring: Scored between 0-100. Higher scores mean more independence. The areas of use of this index are rehabilitation, post-stroke independence assessment, neurological and geriatric patients. It is a short and easy-to-use index.

Routine Blood Values Examination

时间窗: At the time of enrollment

Routine blood tests consist of standard biochemistry, hemogram, and electrolyte tests that evaluate the general health status of the individual. This assessment was not developed by any specific author; it is standardized by medical guidelines and laboratory practices.

Evaluation of sleep quality

时间窗: At the time of enrollment

PSQI (Pittsburgh Sleep Quality Index): PSQI was developed by Daniel J. Buysse and colleagues (1989). It is used to evaluate sleep quality and sleep disorders. Sub-dimensions: Subjective Sleep Quality, Sleep Latency (Time to Fall Asleep), Sleep Duration, Sleep Efficiency, Sleep Disorders, Medication Use, Daytime Functioning. Scoring: Scored between 0-21; 5 and above indicates poor sleep quality.

The physical activity level

时间窗: At the time of enrollment

The physical activity level will be assessed. The International Physical Activity Questionnaire (IPAQ) was developed by the World Health Organization and an international consortium. It is a standard tool for assessing physical activity level. This questionnaire was developed by Craig et al. (2003). The scale has 3 categories. These are: Categories: Low Activity, Moderate Activity, High Activity. It is a questionnaire frequently used in studies related to sports sciences, public health and physical activity level.

Balance assessment

时间窗: At the time of enrollment

Balance assessment will be evaluated with the Berg Balance Scale. The Berg Balance Scale was developed by Katherine Berg and her colleagues in 1992. The Berg Balance Scale is a clinical assessment tool used to assess individuals' risk of falling, measure functional balance levels, and monitor the effectiveness of rehabilitation programs. Total Number of Items on the Scale: 14 items. Scoring: Each item is scored between 0 and 4 (0 = cannot perform the task, 4 = performs the task completely). Total Score Range: 0-56.

Neuropathy evaluation

时间窗: At the time of enrollment

Neuropathy assessment will be done with the Michigan Neuropathy Assessment Questionnaire. The Michigan Neuropathy Assessment Questionnaire was developed by William H. Herman and colleagues (1994). It is used to assess diabetic neuropathy. The questionnaire asks about the patient's neuropathy symptoms (tingling, numbness, pain in the feet, etc.). Clinical assessment findings such as tenderness in the feet, loss of reflexes, and thinning of the skin will be examined.